A RECENT meta-analysis supports administration of N-acetylcysteine prophylaxis to prevent contrast-induced nephropathy, especially in high-risk patients. Researchers also noted that the drug is inexpensive and readily available, and has few side effects.

Administering N-acetylcysteine (NAC) prior to cardiac catheterization may protect patients from contrast-induced nephropathy (CIN), according to a Canadian study.

RADIOCONTRAST NEPHROPATHY (RCN) is an uncommon complication in acute stroke patients undergoing emergency CT angiography (CTA), according to Canadian researchers.

Fenoldopam delivered into the renal artery may help prevent contrast-induced nephropathy (CIN).

SODIUM BICARBONATE may increase the risk of contrast nephropathy (CN), recent findings suggest.

A large Swedish study of patients undergoing coronary procedures shows that renal failure is more likely to develop with the use of an iso-osmolar rather than low-osmolar contrast media.